Background Methamphetamine has long been considered as a neurotoxic substance
causing cognitive deficits. Recently, however, the magnitude and the clinical significance of …

Methamphetamine (MA) is a highly addictive psychostimulant drug that principally affects the
monoamine neurotransmitter systems of the brain and results in feelings of alertness …

Aims To examine the literature regarding clinical pharmacokinetics, direct effects and
adverse clinical outcomes associated with methamphetamine use. Methods Relevant …

This review provides a critical analysis of the central nervous system effects of acute and
chronic methamphetamine (MA) use, which is linked to numerous adverse psychosocial …

Methamphetamine (METH) is an illicit psychostimulant that is widely abused in the world.
Several lines of evidence suggest that chronic METH abuse leads to neurodegenerative …

Methamphetamine (MA) is one of the most commonly abused illicit substances worldwide.
Among other problems, abuse of the drug has been associated with reduced cognitive …

Despite aggressive efforts to contain it, methamphetamine use disorder continues to be
major public health problem; and with generic behavioral therapies still the mainstay of …

Understanding the relationship between the molecular mechanisms underlying neurotoxicity
of high-dose methamphetamine (METH) and related clinical manifestations is imperative for …

Developed as an amphetamine derivative, methamphetamine quickly became a popular
medication during the 1940s and 1950s, prescribed for a variety of indications. Extensive …

Increasing evidence suggests a role of neuroinflammation in substance use disorders
(SUDs). This Review presents findings from neuroimaging studies assessing brain markers …